Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis

Patients with ulcerative colitis (UC) have low response rates to anti-integrin medications, necessitating the identification of noninvasive biomarkers for predicting remission to anti-integrin therapy. In this study, patients with moderate to severe UC commencing anti-integrin therapy (n = 29), inac...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Fang, Huaying, Hong, Na, Lv, Chaolan, Zhu, Qihua, Feng, Yinping, Wang, Bo, Tian, Jiashuang, Yu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269848/
https://www.ncbi.nlm.nih.gov/pubmed/37199618
http://dx.doi.org/10.1128/spectrum.01457-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269848/
https://www.ncbi.nlm.nih.gov/pubmed/37199618
http://dx.doi.org/10.1128/spectrum.01457-23

Ejemplares similares